The shares of Teradata Corporation (NYSE:TDC) has been pegged with a rating of Outperform by BMO Capital Markets in its latest research note that was published on February 10, 2020. The Technology company has also assigned a $27 price target. BMO Capital Markets wasn’t the only research firm that published a report of Teradata Corporation, with other equities research analysts also giving their opinion on the stock. BMO Capital Markets advised investors in its research note published on November 11, 2019, to Market Perform the TDC stock while also putting a $30 price target. The stock had earned Hold rating from Stifel Markets when it published its report on November 08, 2019. That day the Stifel set price target on the stock to $25. BofA/Merrill was of a view that TDC is Neutral in its latest report on November 08, 2019. Citigroup thinks that TDC is worth Sell rating. This was contained in the firm’s report on March 20, 2019 in which the stock’s price target was also moved to 36.
The price of the stock the last time has raised by 2.19% from its 52-Week high price while it is -52.73% than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 33.43.
The shares of the company added by 1.52% during the trading session on Wednesday, reaching a low of $23.01 while ending the day at $23.36. During the trading session, a total of 1.67 million shares were traded which represents a -22.73% decline from the average session volume which is 1.36 million shares. TDC had ended its last session trading at $23.01. Teradata Corporation currently has a market cap of $2.85 billion, while its P/E ratio stands at 185.40, while its P/E earnings growth sits at 10.91, with a beta of 1.21. Teradata Corporation debt-to-equity ratio currently stands at 1.81, while its quick ratio hovers at 1.20 TDC 52-week low price stands at $22.86 while its 52-week high price is $49.42.
The company in its last quarterly report recorded $0.07 earnings per share which is above the predicted by most analysts. The Teradata Corporation generated 528.0 million in revenue during the last quarter. In the second quarter last year, the firm recorded $0.16 earnings per share. Compared to the same quarter last year, the firm’s revenue was down by -71.43%. Teradata Corporation has the potential to record 0.81 EPS for the current fiscal year, according to equities analysts.
Investment analysts at Wells Fargo published a research note on January 08, 2020 where it informed investors and clients that Bruker Corporation (NASDAQ:BRKR) is now rated as Overweight. Their price target on the stock stands at $60. Citigroup also rated BRKR as Initiated on January 07, 2020, with its price target of $52 suggesting that BRKR could surge by 7.27% from its current share price. Even though the stock has been trading at $51.44/share, analysts expect it to down by -1.75% to reach $54.50/share. It started the day trading at $51.33 and traded between $49.75 and $50.54 throughout the trading session.
A look at its technical shows that BRKR’s 50-day SMA is 50.95 while its 200-day SMA stands at 46.46. The stock has a high of $54.49 for the year while the low is $35.23. The stock, however, witnessed a rise in its short on 01/31/20. Compared to previous close which recorded 2.63 M shorted shares, the short percentage went lower by -6.82%, as 2.45M TDC shares were shorted. At the moment, only 2.57% of Bruker Corporation shares were sold short. The company’s P/E ratio currently sits at 38.38, while the P/B ratio is 9.22. The company’s average trading volume currently stands at 514.66K shares, which means that the short-interest ratio is just 5.10 days. Over the past seven days, the company moved, with its shift of 1.40%. Looking further, the stock has raised 5.03% over the past 90 days while it gained 22.64% over the last six months.
The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. The T. Rowe Price Associates, Inc. (I. sold more BRKR shares, decreasing its portfolio by -0.27% during the last quarter. This move now sees The T. Rowe Price Associates, Inc. (I. selling -78,765 shares in the last quarter, thus it now holds 29,612,420 shares of BRKR, with a total valuation of $1,464,926,417. Fidelity Management & Research Co. meanwhile bought more BRKR shares in the recently filed quarter, changing its stake to $746,310,208 worth of shares.
Similarly, The Vanguard Group, Inc. increased its Bruker Corporation shares by 1.68% during the recently filed quarter. After buying 10,984,258 shares in the last quarter, the firm now controls 181,961 shares of Bruker Corporation which are valued at $543,391,243. In the same vein, BlackRock Fund Advisors increased its Bruker Corporation shares by during the most recent reported quarter. The firm bought 77,421 shares during the quarter which increased its stakes to 4,828,625 shares and is now valued at $238,872,079. Following these latest developments, around 25.00% of Bruker Corporation stocks are owned by institutional investors and hedge funds.